Comparing the Effect of Melatonin, Diazepam, and Placebo on Decreasing the Level of Anxiety Preoperatively

NCT ID: NCT06103188

Last Updated: 2025-01-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

87 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-02

Study Completion Date

2023-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare the effect of melatonin, diazepam, and placebo on the level of anxiety in patients undergoing surgery. The main question it aims to answer is:

• Is melatonin effective in reducing the anxiety of patients undergoing surgery? Participants will be asked to answer a questionnaire then they will receive either melatonin, diazepam, or placebo, and then after an hour, they will answer the same questionnaire again.

Researchers will compare melatonin, diazepam, and placebo to see if melatonin is as effective in reducing the level of anxiety as diazepam in patients undergoing surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anxiety is a tense unpleasant sensation experienced by many individuals secondary to their concerns or due to the anticipation of an unpleasant experience like a surgery. Even with the advancement of medical treatment, preoperative anxiety remains a widespread complaint that affects the patients psychologically and physically, and at the same time adversely affecting the outcome of the operation and the experience of the patient.

In this triple-blind, randomized clinical study, we aim to compare melatonin to diazepam regarding its efficacy in reducing preoperative anxiety, as well as assessing multiple other effects such as sedation, orientation, and cognition, by applying validated tools to patients undergoing elective surgeries before and after administering the premedication.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Preoperative Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

A 5mg vitamin B12 pill

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

The placebo pill will be given to the patients 1 hour prior to their planned surgery.

Diazepam

A 5mg diazepam pill

Group Type ACTIVE_COMPARATOR

Diazepam

Intervention Type DRUG

Diazepam will be given to the patients 1 hour prior to their planned surgery.

Melatonin

A 5mg melatonin pill

Group Type EXPERIMENTAL

Melatonin

Intervention Type DRUG

Melatonin will be given to the patients 1 hour prior to their planned surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

The placebo pill will be given to the patients 1 hour prior to their planned surgery.

Intervention Type DRUG

Diazepam

Diazepam will be given to the patients 1 hour prior to their planned surgery.

Intervention Type DRUG

Melatonin

Melatonin will be given to the patients 1 hour prior to their planned surgery.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA 1 or 2
* Posted for general anesthesia
* Aging between 18 and 65 years

Exclusion Criteria

* Allergy to any of the drugs under study
* Pregnancy
* Illiteracy
* Any mental illness
* Taking antipsychotics, antidepressants, anxiolytics, or sedatives
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Jordan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Omar Ismail

Principle Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Omar Ismail

Role: PRINCIPAL_INVESTIGATOR

University of Jordan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jordan University Hospital

Amman, , Jordan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Jordan

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Basel BOMP-AID Randomized Trial
NCT03438526 RECRUITING PHASE4
Melatonin for Delirium Prophylaxis
NCT02282241 WITHDRAWN PHASE4